Literature DB >> 34153315

Alcohol consumption preferentially activates a subset of pro-opiomelanocortin (POMC) producing neurons targeting the amygdala.

Jonna M Leyrer-Jackson1, Lauren E Hood2, M Foster Olive2.   

Abstract

BACKGROUND: Alcohol abuse is a worldwide public health concern and leads to an estimated 90,000 alcohol-related deaths in the United States annually. Alcohol may promote its euphoric and motivational effects, in part, by activating the endogenous opioid system. Pro-opiomelanocortin (POMC) producing neurons located within the arcuate nucleus (ArcN) of the hypothalamus make up one circuit of the endogenous opioid system, and heavily projects to reward-related brain areas such as the amygdala, nucleus accumbens (NAc) and ventral tegmental area (VTA). POMC producing neurons release β-endorphin and other peptides that target opioid receptors within reward areas to elicit their associated rewarding effects. Here we explore ArcN POMC neuronal activation, as assessed via FosB expression, following alcohol consumption to determine whether activation varied within subsets of ArcN POMC projection neurons targeting different reward-related areas.
METHODS: Fluorescent retrobeads were used to label ArcN POMC projection neurons targeting the NAc, amygdala and VTA in POMC-cre mice expressing the reporter tdTomato. Animals (n = 57) were then allowed to voluntarily consume alcohol or water using the drinking-in-the-dark (DID) paradigm, and sacrificed for immunohistochemistry to examine FosB expression within ArcN POMC neurons.
RESULTS: Female mice displayed escalation of alcohol intake across DID sessions, whereas males did not. A greater percent of ArcN POMC neurons target the amygdala over the NAc and VTA, and alcohol consumption preferentially activated ArcN POMC neurons targeting the amygdala over other areas.
CONCLUSION: These findings highlight a novel aspect alcohol-induced activation of the endogenous opioid system, whereby alcohol activates a specific subpopulation of ArcN POMC producing neurons that project primarily to the amygdala.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol; Amygdala; Endogenous opioids; FosB; POMC; Pro-opiomelanocortin

Mesh:

Substances:

Year:  2021        PMID: 34153315      PMCID: PMC8475285          DOI: 10.1016/j.neuropharm.2021.108674

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.273


  86 in total

1.  Differential expression of μ-opioid receptors in the nucleus accumbens, amygdala and VTA depends on liking for alcohol, chronic alcohol intake and estradiol treatment.

Authors:  L M Molina-Martínez; J Juárez
Journal:  Behav Brain Res       Date:  2019-09-21       Impact factor: 3.332

Review 2.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

3.  Differential expression and sensitivity of presynaptic and postsynaptic opioid receptors regulating hypothalamic proopiomelanocortin neurons.

Authors:  Reagan L Pennock; Shane T Hentges
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

Review 4.  Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

Review 5.  Neurocircuitry targets in ethanol reward and dependence.

Authors:  G F Koob; A J Roberts; G Schulteis; L H Parsons; C J Heyser; P Hyytiä; E Merlo-Pich; F Weiss
Journal:  Alcohol Clin Exp Res       Date:  1998-02       Impact factor: 3.455

Review 6.  POMC-derived peptides and their biological action.

Authors:  S Solomon
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

7.  The estrogen receptor α colocalizes with proopiomelanocortin in hypothalamic neurons and binds to a conserved motif present in the neuron-specific enhancer nPE2.

Authors:  Flávio S J de Souza; Sofia Nasif; Rodrigo López-Leal; Diego H Levi; Malcolm J Low; Marcelo Rubinsten
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

8.  The expression of opioid genes in non-classical reward areas depends on early life conditions and ethanol intake.

Authors:  Linnea Granholm; Aniruddah Todkar; Sofia Bergman; Kent Nilsson; Erika Comasco; Ingrid Nylander
Journal:  Brain Res       Date:  2017-05-13       Impact factor: 3.252

9.  Heterogeneity of hypothalamic pro-opiomelanocortin-expressing neurons revealed by single-cell RNA sequencing.

Authors:  Brian Y H Lam; Irene Cimino; Joseph Polex-Wolf; Sara Nicole Kohnke; Debra Rimmington; Valentine Iyemere; Nicholas Heeley; Chiara Cossetti; Reiner Schulte; Luis R Saraiva; Darren W Logan; Clemence Blouet; Stephen O'Rahilly; Anthony P Coll; Giles S H Yeo
Journal:  Mol Metab       Date:  2017-03-01       Impact factor: 7.422

10.  Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.

Authors:  Samuel Turton; James Fm Myers; Inge Mick; Alessandro Colasanti; Ashwin Venkataraman; Claire Durant; Adam Waldman; Alan Brailsford; Mark C Parkin; Gemma Dawe; Eugenii A Rabiner; Roger N Gunn; Stafford L Lightman; David J Nutt; Anne Lingford-Hughes
Journal:  Mol Psychiatry       Date:  2018-06-25       Impact factor: 15.992

View more
  2 in total

1.  Sex differences and the lack of effects of chemogenetic manipulation of pro-opiomelanocortin (POMC) neurons on alcohol consumption in male and female mice.

Authors:  Jonna M Leyrer-Jackson; Lauren E Hood; M Foster Olive
Journal:  Brain Res       Date:  2022-03-31       Impact factor: 3.610

2.  Ethanol consumption activates a subset of arcuate nucleus pro-opiomelanocortin (POMC)-producing neurons: a c-fos immunohistochemistry study.

Authors:  Lauren E Hood; Erin K Nagy; Jonna M Leyrer-Jackson; M Foster Olive
Journal:  Physiol Rep       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.